Francesco Galimi
Turin, 10060, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Heterogeneity and evolution of DNA mutation rates in microsatellite stable colorectal cancer.
Journal: Science translational medicine
Published: May 21, 2025
XENTURION is a population-level multidimensional resource of xenografts and tumoroids from metastatic colorectal cancer patients.
Journal: Nature communications
Published: April 26, 2023
Author Correction: Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts.
Journal: Nature genetics
Published: February 20, 2021
Colorectal cancer residual disease at maximal response to EGFR blockade displays a druggable Paneth cell-like phenotype.
Journal: Science translational medicine
Published: April 26, 2019
Met inhibition revokes IFNγ-induction of PD-1 ligands in MET-amplified tumours.
Journal: British journal of cancer
Published: August 10, 2018
Preclinical Antitumor Activity of a Novel Anti-c-KIT Antibody-Drug Conjugate against Mutant and Wild-type c-KIT-Positive Solid Tumors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 21, 2017
Selective analysis of cancer-cell intrinsic transcriptional traits defines novel clinically relevant subtypes of colorectal cancer.
Journal: Nature communications
Published: January 28, 2016
HER2 activating mutations are targets for colorectal cancer treatment.
Journal: Cancer discovery
Published: August 06, 2015
IGF2 is an actionable target that identifies a distinct subpopulation of colorectal cancer patients with marginal response to anti-EGFR therapies.
Journal: Science translational medicine
Published: January 30, 2015
Astrocytes contribute to gamma oscillations and recognition memory.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: July 30, 2014
Last Updated: 09/26/2026